本页面由Tiger Trade Technology Pte. Ltd.提供服务

North Square Growth Opportunities ETF

20.62
-1.3821-6.28%
盘后:20.640.0242+0.12%16:15 EST
成交量:5,852
成交额:12.57万
市值:5,113.74万
市盈率:- -
高:21.69
开:21.69
低:20.62
收:22.00
52周最高:26.40
52周最低:20.62
股本:248.05万
流通股本:248.05万
量比:2.29
换手率:0.24%
股息:- -
股息率:- -
净资产收益率:--
总资产收益率:--
市净率:--
市盈率(LYR):- -

数据加载中...

公司资料

公司名字:
North Square Growth Opportunities ETF
交易所:
ARCA
成立时间:
2026
员工人数:
- -
公司地址:
200 West Madison Street,Suite 2610,Chicago,Illinois,United States
邮编:
60606
电话:
传真:
312 676 2549
简介:
NeuroSigma is a life sciences company focused on developing bioelectronic products to treat patients suffering from major neurological and neuropsychiatric disorders such as epilepsy and depression. Our non-invasive eTNS system employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. Adjunctive therapies, including adjunctive medications, are used in combination with one or more other therapies and are commonly used by patients who do not respond to first-line treatment with the desired stabilization or improvement of their condition. eTNS is a novel medical treatment that delivers low-intensity electrical current through a single-use patch to stimulate branches of the trigeminal nerve near the surface of the forehead, thereby non-invasively modulating activity in targeted brain regions.